3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Interventions
pembrolizumab
48
Carboplatin
34
Pemetrexed
28
Cisplatin
25
Docetaxel
23
Nivolumab
21
Paclitaxel
20
Gemcitabine
15
Magnetic Resonance Spectroscopy
14
Specimen Handling
12
Radiotherapy
12
Cyclophosphamide
12
Radiosurgery
11
130-nm albumin-bound paclitaxel
11
Erlotinib Hydrochloride
10
Bevacizumab
10
osimertinib
9
Cetuximab
8
Temozolomide
7
Taxes
7
Ipilimumab
7
Biopsy
7
fludarabine
6
Ramucirumab
6
Radiation
6
veliparib
5
tislelizumab
5
durvalumab
5
cemiplimab
5
atezolizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Biological Therapy
×
Thoracic
×
Clear all
NCT07111104
2025-08-08
ARIS
Hopitaux Prives de Metz, Groupe UNEOS
Completed
350 enrolled